--- title: "Spectral AI, Inc. (MDAI.US)" type: "quote" locale: "en" url: "https://longbridge.com/en/quote/MDAI.US.md" symbol: "MDAI.US" name: "Spectral AI, Inc." industry: "医疗器械" --- # Spectral AI, Inc. (MDAI.US) | Item | Detail | |------|--------| | Industry | 医疗器械 | | Location | 美股市场 | | Website | [www.spectral-ai.com](https://www.spectral-ai.com) | ## Company Profile Spectral AI, Inc.是一家专注于美国预测医学诊断的人工智能(AI)公司。该公司提供 DeepView 系统,该系统使用专有的 AI 算法来区分在伤口出现初始时刻肉眼无法识别的完全损伤、部分损伤和健康的人体组织特征;并对伤口在未来特定时间点的愈合能力进行二元预测,以帮助医生做出更准确、及时和知情的决策,关于患者伤口的治疗。其系统还包括 MSI 成像技术,该技术由专有的多光谱光学和传感器组成,能够捕捉受伤组织的图像;以及 AI-Burn 软件。Spectral AI, Inc ## Financial Score > *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.* > Updated: 2026-02-23T04:30:16.000Z **Overall: C (0.56)** **Industry**: Health Care Equipment | Metric | Value | |--------|-------| | Industry Ranking | 91 / 185 | | Industry Median | C | | Industry Average | C | - **Style**: Value - Stocks where the company's main business is in a mature stage. - **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns. ### Score Analysis **Style Score**: #### Growth Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -15.02% | | | Net Profit YoY | -47.18% | | #### Value Score: | Indicator | Value | Rating | |-----------|-------|--------| | P/B Ratio | -5.39 | | | Dividend Ratio | 0.00% | | **Size Score**: #### Market Cap Score: | Indicator | Value | Rating | |-----------|-------|--------| | Market Cap | 44.19M | | #### Revenue Score: | Indicator | Value | Rating | |-----------|-------|--------| | Revenue | 23.17M | | **Multi Score**: C #### Profit Score: B | Indicator | Value | Rating | |-----------|-------|--------| | ROE | 261.03% | A | | Profit Margin | -70.64% | E | | Gross Margin | 42.75% | B | #### Growth Score: D | Indicator | Value | Rating | |-----------|-------|--------| | Revenue YoY | -15.02% | E | | Net Profit YoY | -47.18% | D | | Total Assets YoY | 31.87% | A | | Net Assets YoY | -89.18% | E | #### Cash Score: D | Indicator | Value | Rating | |-----------|-------|--------| | Cash Flow Margin | -141.57% | D | | OCF YoY | -15.02% | E | #### Operating Score: A | Indicator | Value | Rating | |-----------|-------|--------| | Turnover | 1.72 | A | #### Debt Score: E | Indicator | Value | Rating | |-----------|-------|--------| | Gearing Ratio | 153.61% | E | ```chart-data:radar { "title": "Longbridge Financial Score - Spectral AI, Inc.", "chart_type": "radar", "dimensions": [ { "name": "Profit", "grade": "B", "indicators": [ { "name": "ROE", "value": "261.03%", "rating": "A" }, { "name": "Profit Margin", "value": "-70.64%", "rating": "E" }, { "name": "Gross Margin", "value": "42.75%", "rating": "B" } ] }, { "name": "Growth", "grade": "D", "indicators": [ { "name": "Revenue YoY", "value": "-15.02%", "rating": "E" }, { "name": "Net Profit YoY", "value": "-47.18%", "rating": "D" }, { "name": "Total Assets YoY", "value": "31.87%", "rating": "A" }, { "name": "Net Assets YoY", "value": "-89.18%", "rating": "E" } ] }, { "name": "Cash", "grade": "D", "indicators": [ { "name": "Cash Flow Margin", "value": "-141.57%", "rating": "D" }, { "name": "OCF YoY", "value": "-15.02%", "rating": "E" } ] }, { "name": "Operating", "grade": "A", "indicators": [ { "name": "Turnover", "value": "1.72", "rating": "A" } ] }, { "name": "Security", "grade": "E", "indicators": [ { "name": "Gearing Ratio", "value": "153.61%", "rating": "E" } ] } ] } ``` ### Peer Comparison | Rank | Name | Profit | Growth | Operation | Security | Cash | Rating | |------|------|--------|--------|-----------|----------|------|--------| | 01 | 启迪医疗 (US.INSP) | A | B | A | A | B | A | | 02 | Delcath (US.DCTH) | C | A | A | A | A | A | | 03 | 直觉外科 (US.ISRG) | A | B | C | A | B | B | | 04 | 史赛克 (US.SYK) | A | B | C | C | B | B | | 05 | 波士顿科学 (US.BSX) | B | B | C | C | B | B | ## Valuation Analysis | Metric | Current | Industry Ranking | High | Median | Low | |--------|---------|-----------------|------|--------|-----| | PE (TTM) | -2.70 | 100/181 | - | - | - | | PB | -5.39 | 159/181 | - | - | - | | PS (TTM) | 1.91 | 53/181 | 2.16 | 1.97 | 1.17 | | Dividend Yield | 0.00% | - | - | - | - | ## Institutional View ### Analyst Rating Distribution > As of 2026-02-10T05:00:00.000Z Total Analysts: **4** | Rating | Count | Percentage | |--------|-------|-----------| | Buy | 2 | 50% | | Overweight | 0 | 0% | | Hold | 0 | 0% | | Underweight | 0 | 0% | | Sell | 0 | 0% | ### Target Price Forecast | Metric | Price | |--------|-------| | Current Price | 1.44 | | Highest Target | 7.45 | | Lowest Target | 3.00 | ## References - [Company Overview](https://longbridge.com/en/quote/MDAI.US/overview.md) - Shareholders, executives, business segments - [Financials](https://longbridge.com/en/quote/MDAI.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan - [Topics & Discussions](https://longbridge.com/en/quote/MDAI.US/topics.md) - Community topics and discussions --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.